FDA Updates Disclosure Rules On Medical Device Changes
Law360, New York (February 7, 2014, 7:57 PM EST) -- The U.S. Food and Drug Administration on Friday updated its policies on how medical device makers disclose manufacturing and design changes to previously approved products, a process intended to keep regulators apprised of alterations that could influence safety or effectiveness.
In its finalized guidance, the FDA focused on annual reports for riskier Class III devices that are subject to so-called premarket approval, or PMA.
"Annual reports are one of the important tools that FDA relies on to gather information about the device in its post-approval setting," the agency said.
The timing of annual reports corresponds to a device's original approval date....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!